Showing content from https://patents.google.com/scholar/13973326603624504505 below:
Burke et al., 2011 - Google Patents
Burke et al., 2011 - Google PatentsIllumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy
Burke et al., 2011
View HTML
-
Document ID
-
13973326603624504505
-
Author
-
Burke C
-
Mason J
-
Surman S
-
Jones B
-
Dalloneau E
-
Hurwitz J
-
Russell C
-
Publication year
-
2011
-
Publication venue
-
PLoS pathogens
External Links
Snippet
The parainfluenza viruses (PIVs) are highly contagious respiratory paramyxoviruses and a leading cause of lower respiratory tract (LRT) disease. Since no vaccines or antivirals exist, non-pharmaceutical interventions are the only means of control for these pathogens. Here â¦
Continue reading at journals.plos.org (HTML) (other versions)
- 230000005540 biological transmission 0 title abstract description 65
Classifications The classifications are assigned by a computer and are not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense
- C12N2760/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses negative-sense ssRNA Viruses negative-sense
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
Similar Documents Publication Publication Date Title Burke et al. 2011 Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy Hamelin et al. 2010 Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets Dortmans et al. 2010 The viral replication complex is associated with the virulence of Newcastle disease virus Karron et al. 2003 A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants US10329584B2 (en) 2019-06-25 Modified Sendai virus vaccine and imaging vector Lemon et al. 2015 Recombinant subgroup B human respiratory syncytial virus expressing enhanced green fluorescent protein efficiently replicates in primary human cells and is virulent in cotton rats Liu et al. 2013 A live attenuated human metapneumovirus vaccine strain provides complete protection against homologous viral infection and cross-protection against heterologous viral infection in BALB/c mice Zhan et al. 2007 Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B Wen et al. 2015 Development of a novel thermostable Newcastle disease virus vaccine vector for expression of a heterologous gene Aerts et al. 2015 Effect of in vitro syncytium formation on the severity of human metapneumovirus disease in a murine model Zhao et al. 2022 An influenza virus vector candidate vaccine stably expressing SARS-CoV-2 receptor-binding domain produces high and long-lasting neutralizing antibodies in mice Ogonczyk-Makowska et al. 2024 Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice Rennick et al. 2020 Recombinant subtype A and B human respiratory syncytial virus clinical isolates co-infect the respiratory tract of cotton rats Hao et al. 2021 Development of improved mumps vaccine candidates by mutating viral mRNA cap methyltransferase sites in the large polymerase protein Burke et al. 2015 Relationships among dissemination of primary parainfluenza virus infection in the respiratory tract, mucosal and peripheral immune responses, and protection from reinfection: a noninvasive bioluminescence-imaging study Tan et al. 2007 Characterization of human metapneumovirus infection of myeloid dendritic cells Wei et al. 2017 Developing a platform system for gene delivery: amplifying virus-like particles (AVLP) as an influenza vaccine Schaap-Nutt et al. 2010 Growth restriction of an experimental live attenuated human parainfluenza virus type 2 vaccine in human ciliated airway epithelium in vitro parallels attenuation in African green monkeys Skiadopoulos et al. 2002 The recombinant chimeric human parainfluenza virus type 1 vaccine candidate, rHPIV3â1cp45, is attenuated, immunogenic, and protective in African green monkeys FR3084079A1 (en) 2020-01-24 NEW MITIGATED VIRAL STRAIN AND ITS USE AS A VACCINE TW202208399A (en) 2022-03-01 Chimeric rsv and coronavirus proteins, immunogenic compositions, and methods of use Mason et al. 2013 Influence of antigen insertion site and vector dose on immunogenicity and protective capacity in Sendai virus-based human parainfluenza virus type 3 vaccines CA3215468A1 (en) 2022-11-03 Chimeric newcastle disease virus expressing apmv hn and f proteins WO2020120910A1 (en) 2020-06-18 Production of viral vaccines on an avian cell line Yu et al. 2012 Replication and pathogenicity of attenuated human metapneumovirus F mutants in severe combined immunodeficiency mice
RetroSearch is an open source project built by @garambo
| Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.4